On July 10, Xenon Pharmaceuticals fell 5.07% in regular trading, trading at $67.3 USD/share, with Turnover of $24.06 million.
Within the Biotechnology sector where Xenon Pharmaceuticals belongs, the sector saw broad-based weakness. Among individual stocks, AbbVie down 1.16%, Moderna, Inc. down 9.62%, Ionis Pharmaceuticals down 7.89%, Alnylam Pharmaceuticals down 2.19%, Argenx SE down 3.35%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)